Methods of treating inflammatory diseases, e.g., diseases associated with inflammatory CD14+/CD16 monocytes, e.g., amyotrophic lateral sclerosis (ALS), stroke, and glaucoma, using compounds such as small molecules and antibodies that target CCR2 or CCL2.
展开▼